Sources | Names Used |
---|---|
CTRPv2 | compound 1B |
PharmacoGx | compound 1B |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RFC1 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
mRNA | ZBTB8OS | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
mRNA | TAF5 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.05 |
mRNA | CNTN3 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
mRNA | TADA1 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.05 |
mRNA | CRYZL1 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
mRNA | ATP5B | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
mRNA | SGMS1 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
mRNA | RPL34 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.05 |
mRNA | THG1L | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |